Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication-Reference-Cited by-同舟云学术

Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication

Published:2011-03-01 Issue:1 Volume:8 Page:
ISSN:1742-6405
Container-title:AIDS Research and Therapy
language:en
Short-container-title:AIDS Res Ther

Author:

Esposito Antonella,Conti Valentina,Cagliuso Maria,Pastori Daniele,Fantauzzi Alessandra,Mezzaroma Ivano

Abstract

Abstract In HIV-1 infected patients, increase of liver enzymes may be mainly due to viral coinfections, alcohol intake, hepatotoxic drugs or autoimmune diseases. Three cases of aminotransferase elevation occurred during a phase of uncontrolled viral replication combined with a severe immunodeficiency and resolved by an effective HAART are described, focusing on the etio-pathogenetic role possibly played by HIV-1 infection.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Virology,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1186/1742-6405-8-9.pdf

Reference14 articles.

1. Pol S, Lebray P, Vallet-Pichard A: HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms. Clin Infect Dis. 2004, 38 (Suppl 2): 65-72. 10.1086/381499.

2. Akhtar MA, Mathieson K, Arey B, Post J, Prevette R, Hillier A, Patel P, Ram LJ, Van Thiel DH, Nadir A: Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. Eur J Gastroenterol Hepatol. 2008, 20: 1194-1204. 10.1097/MEG.0b013e328305b9e0

3. Sterling RK, Chiu S, Snider K, Nixon D: The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIV-Positive Patients without Hepatitis B or C Coinfections. Dig Dis Sci. 2008, 53: 1375-1382. 10.1007/s10620-007-9999-6

4. Puoti M, Nasta P, Gatti F, Matti A, Prestini K, Biasi L, Carosi G: HIV-Related Liver Disease: ARV Drugs, Coinfection, and Other Risk Factors. J Int Assoc Physicians AIDS Care. 2009, 8: 30-42. 10.1177/1545109708330906.

5. Bongiovanni M, Cicconi P, Landonio S, Meraviglia P, Testa L, Di Biagio A, Chiesa E, Tordato F, Bini T, Monforte A: Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals. Int J Antimicrob Agents. 2005, 26: 88-91. 10.1016/j.ijantimicag.2005.03.003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the role of extracellular vesicles in liver injury induced by HIV;Expert Review of Gastroenterology & Hepatology;2023-07-03

2. Liver Disease Associated With Systemic Viral Infection;Zakim and Boyer's Hepatology;2018